Chemotherapy Biotherapy Certification Exam 2 2023 With Complete Solution Graded and Already Passed.

Resources - CORRECT ANS LESSON 1: Cell cycle - CORRECT ANS g1- increase in size s- dna replicated g2- cell enlarge and ready to divide m phase- 2 hours mitosis - CORRECT ANS 4 stages, prophase, metaphase, anaphase, telophase -chemo targets certain points in the process apoptosis - CORRECT ANS programmed cell death hematopoiesis - CORRECT ANS formation of blood cells & how cells differentiate -myeloid: pre cells mature into RBCs, platelets and WBCs -lymphoid: pre cells- mature into WBCS Principles of Biotherapy: p51-95 immunology - CORRECT ANS -defense against foreign organisms, homeostasis (destroy aged cells), surveillance immune responses - CORRECT ANS innate: primary line of defense, non specific, no memory adaptive: secondary line of defence with specific memry cytokines - CORRECT ANS -effect growth and differentiation of WBC -interferons, tumor necrosis factors, growth factos and interleukins -small protein molecules released by cells throughout body providing comunication between cells of the immune system -regular antiboddy production and function of b cells vaccines for cancer prevention - CORRECT ANS -hep B prevents hepatitis and hepatocellular carcinoma -hpv vaccine filgrastim aka neupogen - CORRECT ANS SC or IV to derease infection in patients with neutropenic fever associated with myelosuppressive anticancer treatments for nonmyeloid malignancies tbo-filgramstim/ pegfilgrastim - CORRECT ANS reduce duration of neutroenia in patients with non myeloid malignancies palifermin - CORRECT ANS IV to dec incidence of oral mucositis in patients with hem malignanies before BMT sargramostim - CORRECT ANS aka leukine - patients with AML following chemo to shorten neutrophil recovery and reduce incidence of infection IFN gamma - CORRECT ANS reduce frequency and severity o infections related to granulomatous disease aldeleukin - CORRECT ANS treat renal cell carcinoma and metastatic melanoma oprevelkin - CORRECT ANS prevent severe thrombocytopenia and refuce need for platelet transfusions in patients with nonmyeloid malig plerixafor - CORRECT ANS with filgrastim to mobilize hematopoeitc stem cells for collection from peripheral blood of patients sipuleucel - CORRECT ANS castrate resistant prostate cancer rituximab - CORRECT ANS rituxan- treatment of relapsed or refractory low grade follicular b cell NHL_ first line traetment in combo with chemo in patients with response -can treat severe rheumatoid arthritis 2 | P a g e Chemotherap